Menu

Libutti Laboratory - Select Publications

Yuan Z, Gardiner JC, Maggi EC, Adem A, Zhang G, Lee S, Romanienko P, Du YN, Libutti SK. Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation. Cancer Gene Ther. 2018 Sep 7. doi: 10.1038/s41417-018-0046-x. PubMed PMID: 30190513.

Nilubol N, Yuan Z, Paciotti GF, Tamarkin L, Sanchez C, Gaskins K, Freedman EM, Cao S, Zhao J, Kingston DGI, Libutti SK, Kebebew E. Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors. J Natl Cancer Inst. 2018 Sep 1;110(9):1019-1029. doi: 10.1093/jnci/djy003. PubMed PMID: 29481652. 

Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C. Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model. Front Genet. 2018 Jan 23;9:6. doi: 10.3389/fgene.2018.00006. eCollection 2018. PubMed PMID: 29410677; PubMed Central PMCID: PMC5787102.

Chandra D, Selvanesan BC, Yuan Z, Libutti SK, Koba W, Beck A, Zhu K, Casadevall A, Dadachova E, Gravekamp C. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effectOncotarget. 2017 Mar 28;8(13):20729-20740. doi: 10.18632/oncotarget.15117. PubMed PMID: 28186976; PubMed Central PMCID: PMC5400540.

Kwon M, Kim J-H, Rybak Y, Luna A, Choi CH, Chung J-Y, Hewitt SM, Adem A, Tubridy E, Lin J, Libutti SK; Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer; Oncotarget, 2016 7(47):77052-77070.

Yuan Z, Sánchez Claros C, Suzuki M, Maggi EC, Kaner JD, Kinstlinger N, Gorecka J, Quinn TJ, Geha R, Corn A, Pastoriza J, Jing Q, Adem A, Wu H, Alemu G, Du YC, Zheng D, Greally JM, Libutti SK. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis. Oncotarget. 2016 Mar 15;7(11):12633-50. doi: 10.18632/oncotarget.7279. PubMed PMID: 26871472; PubMed Central PMCID: PMC4914310.

Smith TL, Yuan Z, Cardó-Vila M, Sanchez Claros C, Adem A, Cui MH, Branch CA, Gelovani JG, Libutti SK, Sidman RL, Pasqualini R, Arap W. AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreasProc Natl Acad Sci U S A. 2016 Mar 1;113(9):2466-71. doi: 10.1073/pnas.1525709113. Epub 2016 Feb 16. PubMed PMID: 26884209; PubMed Central PMCID: PMC4780640.

McKimpson WM, Yuan Z, Zheng M, Crabtree JS, Libutti SK, Kitsis RN. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth. PLoS One. 2015 Dec 28;10(12):e0145792. doi: 10.1371/journal.pone.0145792. eCollection 2015. PubMed PMID: 26709830; PubMed Central PMCID: PMC4692498.

Kwon M, Libutti SK; Filamin A interacting protein 1-like as a therapeutic target in cancer; Expert Opinion on Therapeutic Targets, 2014 18:1435-47.

Kwon M, Lee SJ, Wang Y, Rybak Y, Luna A, Reddy S, Adem A, Beaty BT, Condeelis JS, Libutti SK; Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis; International Journal of Cancer, 2014 135:48–60.

 

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health